Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism
Ying Hu, Tahereh Setayesh, Farzam Vaziri, et al.
Molecular Therapy (2023) Vol. 31, Iss. 6, pp. 1829-1845
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Multi-pathway targeted therapy of MASH-HCC using miR-22
Ying Hu, Tahereh Setayesh, Dongguang Wei, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Immune regulation and therapeutic application of T regulatory cells in liver diseases
Ananya Ajith, Makram Merimi, Mandana Kazem Arki, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Therapeutic effects of tetrahedral framework nucleic acids and tFNAs‐miR22 on retinal ischemia/reperfusion injury
Xiaoxiao Xu, Yanyan Fu, Hongmei Luo, et al.
Cell Proliferation (2024) Vol. 57, Iss. 11
Open Access | Times Cited: 6
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights
Farzam Vaziri, Tahereh Setayesh, Ying Hu, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 5
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities
Khadijeh Mahboobnia, Dianne J. Beveridge, George C. Yeoh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9393-9393
Open Access | Times Cited: 5
The roles and mechanisms of coding and noncoding RNA variations in cancer
Sang Yean Kim, Min Jeong Na, Sungpil Yoon, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 9, pp. 1909-1920
Open Access | Times Cited: 4
NS3 of hepatitis C virus drives hepatocellular carcinoma progression through a novel RNA‐interference pathway
Yajun Liang, Jian Luo, Liya Hu, et al.
Journal of Cell Communication and Signaling (2025) Vol. 19, Iss. 2
Open Access
Mapping the knowledge domains of literature on hepatocellular carcinoma and liver failure: a bibliometric approach
Jun Pu, Zhao Ya-min, Siming Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
Ilaria Leoni, Giuseppe Galvani, Elisa Monti, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3808-3808
Open Access
The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model
Tahereh Setayesh, Ying Hu, Farzam Vaziri, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
CAF-derived miR-642a-3p supports migration, invasion, and EMT of hepatocellular carcinoma cells by targeting SERPINE1
Shuo Zhang, Gang Cao, Shuijie Shen, et al.
PeerJ (2024) Vol. 12, pp. e18428-e18428
Open Access | Times Cited: 3
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
Mickaël Jouve, Rodolphe Carpentier, Sarra Kraiem, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5557-5557
Open Access | Times Cited: 8
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 766-766
Open Access | Times Cited: 2
Identification and validation of a novel glycolysis-related ceRNA network for sepsis-induced cardiomyopathy
Lulu Cheng, Jiabin Liang, Fangmei Xie, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
miRNAs in HCC, pathogenesis, and targets
Guisheng Song, Xiaofan Yu, Hongtao Shi, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma
Tahereh Setayesh, Ying Hu, Farzam Vaziri, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 292-303
Open Access | Times Cited: 6
Non-coding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
(2024)
Open Access | Times Cited: 1
miR-557 suppresses hepatocellular carcinoma cell proliferation and migration via downregulating CBX4
XULONG SUN, WENTAO DING, Chao Jiang, et al.
Biocell (2024) Vol. 48, Iss. 7, pp. 1071-1079
Open Access | Times Cited: 1
Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review)
Minghe Wang, Xuejing Wang, Yanqi Wang, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access | Times Cited: 1
The role of viral infection in implantation failure: direct and indirect effects
Marzieh Rezaei, Mohsen Moghoofei
Reproductive Biology and Endocrinology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Targeting STK26 and ATG4B: miR-22-3p as a modulator of autophagy and tumor progression in HCC
Kai Li, Yaping Bai, Jingtong Wang, et al.
Translational Oncology (2024) Vol. 51, pp. 102214-102214
Open Access | Times Cited: 1
miR-22a targets p62/SQSTM1 to negatively affect autophagy and disease resistance of grass carp (Ctenopharyngodon idella)
Hongyan Yu, Lingli Xie, Zheyan Chen, et al.
Fish & Shellfish Immunology (2023) Vol. 142, pp. 109124-109124
Closed Access | Times Cited: 2
Strategic advancement of E3 ubiquitin ligase in the management of hepatocellular carcinoma
Yangyang Miao, Shun‐Yi Wang, Jiahao Zhang, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access
Identification of Plasma Exosomal Microrna-194-5p as a Predictor and Sensitizer for the Efficacy of Immunotherapy in Hepatocellular Carcinoma
Jianhui Zhao, Yang Yixiao, Yingying Bao, et al.
(2024)
Closed Access
ADAR1-regulated miR-142-3p/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma
Haoyuan Xu, Wanpeng Li, Kai Xue, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 116-129
Open Access
Page 1 - Next Page

Scroll to top